21 May 2025
Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice
Sponsored by Meril
Anchorperson:
I. J. Amat-Santos
Spokesperson:
J. Wykrzykowska
Summary
This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and sizing strategies critical for TAVI planning, as well as procedural best practices for successful implantation of the Myval Octapro THV.
Learning Objectives
- To learn from the experts best-in-the-class TAVI practice: pre-procedural (imaging, sizing rationale, treatment strategy), procedural tips and tricks and post-procedural management
- To discover more about one-year clinical update on the Landmark RCT and its relevance in clinical practice
- To know about the novel Myval Octapro THV - Key features, the procedural impact and potential clinical benefits